Martingale Asset Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-42,338
| Closed | -$231K | – | 837 |
|
|
2024
Q2 | $231K | Sell |
42,338
-6,858
| -14% | -$37.4K | 0.01% | 736 |
|
|
2024
Q1 | $492K | Sell |
49,196
-10,507
| -18% | -$105K | 0.01% | 620 |
|
|
2023
Q4 | $244K | Hold |
59,703
| – | – | 0.01% | 729 |
|
|
2023
Q3 | $231K | Sell |
59,703
-23
| -0% | -$89 | ﹤0.01% | 726 |
|
|
2023
Q2 | $356K | Buy |
59,726
+2,811
| +5% | +$16.8K | 0.01% | 671 |
|
|
2023
Q1 | $186K | Hold |
56,915
| – | – | ﹤0.01% | 788 |
|
|
2022
Q4 | $225K | Buy |
56,915
+700
| +1% | +$2.77K | ﹤0.01% | 771 |
|
|
2022
Q3 | $338K | Hold |
56,215
| – | – | 0.01% | 696 |
|
|
2022
Q2 | $362K | Buy |
56,215
+17,529
| +45% | +$113K | 0.01% | 709 |
|
|
2022
Q1 | $320K | Buy |
+38,686
| New | +$320K | ﹤0.01% | 715 |
|